Bisphosphonates are generally recommended for those with osteoporosis, yet there seems to be controversy as to whether or not they are appropriate for patients who have not yet had a fracture.
Iibisphosphonates ziye zicetyiswe ukuba zisetyenziswe ngabantu abanesifo sobuthathaka nokuba qoboqobo kwamathambo, kodwa kukho ingxokozelo malunga nokuba kufanelekile kusini na ukuba zinikwe izigulana ezingakhange zophuke.